News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Frazier Life Sciences VIII, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2022 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Bought 250,000 shares
@ $20, valued at
$5M
|
|
| 08/09/2022 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 14.6% stake in Arcutis Biotherapeutics, Inc. |
| 02/15/2022 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Bought 112,665 shares
@ $7.1006, valued at
$800k
|
|
| 02/15/2022 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 10.8% stake in Alpine Immune Sciences, Inc. |
| 01/28/2022 |
SC 13G/A
| Frazier Life Sciences VIII, L.P. reports a 8.4% stake in Sierra Oncology, Inc. |
| 09/21/2021 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 10% stake in Alpine Immune Sciences, Inc. |
| 09/21/2021 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Disposed/sold 1,200,000 shares
@ $0
Granted 1,200,000 warrants
@ $0.001, valued at
$1.2k
|
|
| 05/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/12/2021 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 16.9% stake in Arcutis Biotherapeutics, Inc. |
| 05/04/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/09/2021 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 21.7% stake in Arcutis Biotherapeutics, Inc. |
| 02/04/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/06/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 24.1% stake in Arcutis Biotherapeutics, Inc. |
| 07/30/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/18/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 2.9% stake in Entasis Therapeutics Holdings Inc. |
| 04/29/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 2% stake in Sierra Oncology, Inc. |
| 03/23/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 7.9% stake in Entasis Therapeutics Holdings Inc. |
| 02/07/2020 |
SC 13D
| Frazier Life Sciences VIII, L.P. reports a 27.7% stake in Arcutis Biotherapeutics, Inc. |
| 02/06/2020 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Arcutis Biotherapeutics, Inc.|
Txns:
| Converted 6,360,272 shares
@ $0
Converted 2,099,019 shares
@ $0
Converted 1,074,467 shares
@ $0
Bought 500,000 shares
@ $17, valued at
$8.5M
Converted 6,360,272 preferred shares
@ $0
Converted 2,099,019 preferred shares
@ $0
Converted 1,074,467 preferred shares
@ $0 |
|
| 01/31/2020 |
3/A
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 3/A on Arcutis Biotherapeutics, Inc. |
| 01/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/16/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 7.1% stake in Aptinyx Inc. |
| 01/13/2020 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Entasis Therapeutics Holdings Inc.|
Txns:
| Sold 50,000 shares
@ $5.0002, valued at
$250k
|
|
| 01/13/2020 |
SC 13D/A
| Frazier Life Sciences VIII, L.P. reports a 9.8% stake in Entasis Therapeutics Holdings Inc. |
| 01/22/2019 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Bought 372,439 shares
@ $5.37, valued at
$2M
Bought 145,251 warrants
@ $12.74, valued at
$1.9M
|
|
| 10/09/2018 |
SC 13D
| Frazier Life Sciences VIII, L.P. reports a 10.3% stake in Entasis Therapeutics Holdings Inc. |
| 10/02/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2018 |
3
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 3 on Entasis Therapeutics Holdings Inc. |
| 06/26/2018 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Converted 1,047,450 shares
@ $0
Converted 1,197,076 shares
@ $0
Converted 795,553 shares
@ $0
Bought 150,000 shares
@ $16, valued at
$2.4M
Converted 28,895,188 convertible preferred
@ $0
Converted 33,022,786 convertible preferred
@ $0
Converted 21,946,301 convertible preferred
@ $0 |
|
| 06/20/2018 |
3
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 3 on Aptinyx Inc. |
| 07/28/2017 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
|
|